Geron Corporation
USD1.30
-0.02 (-1.52%)
CEO
Harout Semerjian
IPO Date
1996-07-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.33
Prev. Close
$1.32
Day Low
$1.29
Day High
$1.37
52W Low
$1.04
52W High
$2.01
Market Cap
$0.83B
Volume
14.47M
| -13.1 |
| 31 Dec 2023 | FY | 100.0% | -77690.7% | -74.3% | -46.7% | 0.35 | 3.16 | -6.5 |
| 31 Dec 2022 | FY | 100.0% | -23808.9% | -177.4% | -74.5% | 0.70 | 2.35 | -6.5 |
| 31 Dec 2021 | FY | 100.0% | -8335.4% | -91.8% | -51.4% | 0.44 | 4.11 | -3.4 |
| 31 Dec 2020 | FY | -19683.4% | -29888.1% | -35.8% | -27.9% | 0.14 | 6.46 | -5.7 |
| 31 Dec 2019 | FY | -11046.1% | -14901.7% | -50.7% | -41.4% | 0.02 | 5.03 | -3.8 |
| 31 Dec 2018 | FY | -1093.5% | -2534.4% | -15.2% | -14.6% | 0.00 | 21.99 | -6.5 |
| 31 Dec 2017 | FY | -692.2% | -2621.2% | -26.9% | -25.3% | 0.00 | 14.73 | -10.3 |
| 31 Dec 2016 | FY | -138.5% | -479.3% | -24.1% | -22.7% | 0.00 | 14.76 | -11.1 |
| -7.1 |
| 30 Sept 2025 | Q3 | 53.2% | -39.0% | -7.4% | -3.2% | 0.49 | 5.96 | -12.4 |
| 30 Jun 2025 | Q2 | 97.6% | -33.4% | -6.3% | -2.9% | 0.47 | 7.87 | -14.3 |
| 31 Mar 2025 | Q1 | 97.0% | -50.1% | -7.4% | -3.5% | 0.45 | 7.87 | -13.3 |
| 31 Dec 2024 | Q4 | 98.4% | -53.3% | -9.0% | -4.3% | 0.43 | 5.56 | -22.6 |
| 30 Sept 2024 | Q3 | 98.4% | -93.5% | -9.0% | -5.9% | 0.30 | 2.89 | -28.4 |
| 30 Jun 2024 | Q2 | 98.1% | -7639.8% | -22.0% | -15.0% | 0.28 | 3.61 | -10.5 |
| 31 Mar 2024 | Q1 | 100.0% | -18220.4% | -16.1% | -11.5% | 0.25 | 3.67 | -8.6 |
| 31 Dec 2023 | Q4 | 100.0% | -225969.6% | -21.0% | -13.2% | 0.35 | 3.16 | -6.0 |